MONA VELLANKI: Open Payments
NPI 1902383433 · PERTH AMBOY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 12 payments from 6 companies in 2025. Trend: 2023 $142 · 2024 $101 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Lundbeck LLC | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Alkermes, Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: UZEDY, ABILIFY MAINTENA, REXULTI, COBENFY, ARISTADA, INVEGA SUSTENNA.
Industry payments across NJ — which companies pay providers there.
